Susquehanna International Group
BCAB icon

Susquehanna International Group’s BioAtla BCAB Stock Holding History

Susquehanna International Group’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.29K Sell
781
-853
-52% -$9.98K ﹤0.01% 12969
2025
Q4 		$46.4K Sell
1,634
-3,418
-68% -$134K ﹤0.01% 11776
2025
Q3 		$174K Buy
5,052
+3,556
+238% +$82.1K ﹤0.01% 11134
2025
Q2 		$29.6K Buy
1,496
+822
+122% +$16.7K ﹤0.01% 12254
2025
Q1 		$11.7K Sell
674
-3,611
-84% -$77.2K ﹤0.01% 12202
2024
Q4 		$127K Buy
4,285
+690
+19% +$57.9K ﹤0.01% 11148
2024
Q3 		$316K Buy
3,595
+206
+6% +$17.3K ﹤0.01% 9486
2024
Q2 		$232K Buy
3,389
+1,605
+90% +$191K ﹤0.01% 10024
2024
Q1 		$307K Buy
1,784
+597
+50% +$74.2K ﹤0.01% 9653
2023
Q4 		$146K Sell
1,187
-1,338
-53% -$116K ﹤0.01% 11002
2023
Q3 		$215K Buy
2,525
+212
+9% +$27K ﹤0.01% 10082
2023
Q2 		$347K Sell
2,313
-2,826
-55% -$486K ﹤0.01% 9144
2023
Q1 		$689K Buy
5,139
+584
+13% +$105K ﹤0.01% 7764
2022
Q4 		$1.88M Buy
4,555
+3,126
+219% +$1.3M ﹤0.01% 4822
2022
Q3 		$550K Sell
1,429
-1,010
-41% -$331K ﹤0.01% 8233
2022
Q2 		$348K Buy
2,439
+353
+17% +$56.2K ﹤0.01% 9170
2022
Q1 		$521K Buy
2,086
+1,498
+255% +$627K ﹤0.01% 8863
2021
Q4 		$577K Buy
588
+94
+19% +$120K ﹤0.01% 8793
2021
Q3 		$727K Buy
494
+319
+182% +$621K ﹤0.01% 8406
2021
Q2 		$370K Buy
+175
New +$395K ﹤0.01% 10316

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group's BCAB Position: Q1 2026 in Review

Susquehanna International Group reduced its BioAtla (BCAB) stake by 52% in Q1 2026, selling an estimated $9.98K and leaving 781 shares worth $6.29K. The position accounts for ﹤0.01% of the portfolio, ranked #12969.

Susquehanna International Group first reported a position in BCAB in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.88M in Q4 2022. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Susquehanna International Group held 781 shares of BioAtla worth $6.29K as of Q1 2026.
  • Susquehanna International Group sold 853 BioAtla shares in Q1 2026, an estimated $9.98K.
  • BioAtla made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12969 holding.
  • Susquehanna International Group first reported a position in BioAtla in Q2 2021 and has held it in 20 quarters since.
  • Susquehanna International Group's BioAtla position peaked at $1.88M in Q4 2022.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.